|Articles|May 1, 2002
Change in daily dosing may hinder treatment effect of glaucoma drug
Patient compliance is a larger problem than physicians like to admit-especially in chronic diseases, such as glaucoma. However, efficacy must not be compromised by the attempt to simplify dosing regimens.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
2
Pickleball, fireworks, eyecare in space, and IRIS registry data among lead stories from day 1 of AAO 2025
3
Ophthalmic innovation by the decades: The 2010s
4
Tensions rise between STAAR and Broadwood as proposed Alcon deal nears vote
5